1、主编介绍
魏于全院士， 2003年当选中国科学院院士，1959年生，四川南江人，中共党员，华西医科大学本科、硕士，日本京都大学医学博士，教授，博士生导师。原四川大学副校长，华西医院临床肿瘤中心主任与生物治疗国家重点实验室主任，中国医药生物技术协会理事长，国家生物治疗协同创新中心负责人，国家综合性新药研究开发技术大平台负责人， Signal Transduction and Targeted Therapy共同主编、Human Gene Therapy 副主编、Current Molecular Medicine副主编、Current Cancer Drug Targets 负责亚洲地区的编委，Scientific Reports编委等。科技部“973” 项目首席科学家，国家自然科学基金创新研究群体负责人，教育部特聘教授，1997 年国家杰出青年科学基金获得者，国家“百千万人才工程”第一、二层次人选，十五“863” 生物与农业技术领域生物工程技术主题专家组组长，十二五“863” 生物与医学领域生物技术药物主题专家组成员、原中华医学会副会长、原教育部科学技术委员会生物医学学部常务副主任。主要从事肿瘤的生物治疗的基础研究、关键技术开发、产品研发及临床治疗等，有关肿瘤微环境、免疫治疗、基因治疗与靶向药物等相关研究结果已在多种国际杂志上发表SCI论文300多篇。发现了阻断HSP70表达，可诱导癌细胞凋亡。
张康教授目前就职于澳门科技大学。张康教授获得了哈佛大学和麻省理工学院医学博士，以及哈佛大学的遗传学博士学位，也是美国约翰霍普金斯大学威尔玛眼科中心第一位来自中国内地的眼科住院医生。张康教授在医学人工智慧、眼科学、干细胞，生物材料和3D列印，遗传学以及精准医学领域拥有较高造诣，亦拥有丰富临床实践经验和基础科研成果。曾获得Burroughs Wellcome基金会临床科学家转化型研究奖等多项国际奖项，2010年美国最佳眼科医生，2016、2018年眼科最具影响力世界100强榜单。在国际知名期刊包括New England Journal of Medicine, Nature, Science, Cell, Nature Genetics, Nature Medicine, Cell Stem Cell, Molecular Cell, PNAS, JCI等上发表文章200多篇。关于HTRA1基因是黄斑变性的主要易感基因的文章被《科学》评为2006年世界科学十大进展之一，基于AI深度学习诊断眼病和肺炎Cell封面论文被评为《Cell》2018年度最佳论文。
Carlo M. Croce教授，美国国家科学院院士、美国国家艺术与科学院院士、美国国家医学院院士、美国癌症研究院首批一级院士、意大利国家科学院外籍院士、美国俄亥俄州立大学杰出教授，是国际公认的miRNA领域领军人物。Croce教授在肿瘤致病机理方面做出了一系列开创性的研究成果，揭示了许多在白血病、淋巴瘤及其他肿瘤中的突变，首次发现并鉴定了BCL2、ALL1和TCL1基因；首次揭示了miRNA在肿瘤发生过程中的重要作用，掀起了miRNA的研究热潮。在Science、Nature 和Cell 三大主刊发表论文50余篇，H-index超过200，研究成果被他人引用高达十几万次。
2、编委会名单
Editors-in-Chief
Prof. Carlo M. Croce, Institute of Genetics, The Ohio State University, Columbus, Ohio, USA
Prof. Kang Zhang, Center for Biomedicine and Innovations at Faculty of Medicine, Macau University of Science and Technology, China
Prof. Yu-Quan Wei, National/State Key Laboratory of Biotherapy and Clinical Cancer Center, West China Hospital, West China Medical School, Sichuan University, China
Associate Editors
Rami I. Aqeilan, Milton Winograd Chair in Cancer Research, Lautenberg Center for Immunology and Cancer Research, Hebrew University of Jerusalem, Israel
Ashley Bush, University of Melbourne, Australia
Xuetao Cao, Chinese Academy of Medical Science, China
Webster K. Cavenee, Ludwig Institute for Cancer Research University of California, San Diego, USA
Xin-yuan Fu, National University of Singapore, Singapore
Guangping Gao, Microbiology and Physiological Systems, University of Massachusetts Medical School, Massachusetts, USA
Curtis Harris, Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, USA
Zhen Huang, Department of Chemistry & Department of Biology, Georgia State University, Atlanta, Georgia, USA
Yibin Kang, Princeton University, USA
Weimin Li, West China Hospital, Sichuan University, China
Yang Liu, Center for Cancer and Immunology Research, Children's National Medical Center, Washington DC, USA
Qing Richard Lu, West China Second Hospital, Sichuan University,China,Cincinnati Children's Hospital Medical Center, USA
Pralay Maiti, Indian Institute of Technology, Banaras Hindu University, India
Dalla-Favera Riccardo, Cancer Center, Columbia University; Department of Pathology & Cell Biology, Columbia University, USA
Hongbing Shu, Wuhan University, China,
Shao-Cong Sun, University of Texas, MD Anderson Cancer Center, USA
Philip N Tsichlis, Molecular Oncology Research Institute, Tufts Medical Center, USA
Peter K. Vogt, The Scripps Research Institute, USA
Rong Xiang, Nankai University, China
Zhixiong Xiao, College of Life Sciences, Sichuan University, China
Shengyong Yang, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China
Editorial Board Members
Xiuwu Bian, Armed Forces Institute of Pathology, Network Center of Third Military Medical University, Chongqing, China
Guojun Bu, Department of Neuroscience, Mayo Clinic, USA
Shawn Burgess, National Human Genome Research Institute, National Institutes of Health, USA
John C. Byrd, The Ohio State University, USA
George A. Calin, MD Anderson Cancer Center, USA
Thomas Carell, Ludwig-Maximilians-Universität München, Germany
Chong Chen, West China Hospital, Sichuan University, China
Guoqiang Chen, School of Medicine, Shanghai Jiao Tong University, China
Zhijian Chen, UT Southwestern Medical Center,USA
Eros Lazzerini Denchi, The Scripps Research Institute, La Jolla, USA
Miguel Sena Esteves, University of Massachusetts Medical School, USA
David Fruman, University of California, Irvine, USA
Caiyun Fu, Zhejiang Sci-Tech University, China
Xiangdong Fu, Univerisity of California, San Diego, USA
Alan Garen, School of Medicine, Yale University, USA
Mark Ginsberg, University of California, San Diego, USA
JunLin Guan, Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, USA
Junhong Han, West China Hospital, Sichuan University, China
Stephen Hann, Vanderbilt University, Nashville, USA
Nongyue He, Southeast University, China
Matthew Vander Heiden, Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, USA
Philip W. Hinds, Tufts University School of Medicine, USA
Canhua Huang, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China
Wendong Huang, Department of Diabetes Complications and Metabolism, City of Hope National Medical Center, USA
Shile Huang, Louisiana State University Health Sciences Center, USA
Hualiang Jiang, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China
JianSheng Kang, Zhengzhou University, China
Tiebang Kang, Sun Yat-Sen University Cancer Center, China
Kazunori Kataoka, The University of Tokyo, Japan
Guido Kroemer, Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, France
Peng Lei, West China Hospital, Sichuan University, China
Qunying Lei, Department of Biochemstry and Molecular Biology, Fudan University, China
Luyuan Li, State key laboratory of medicinal chemical biology, Nankai University, Tianjin, China
Haitao Li, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, China
Lei Li, MD Anderson Cancer Center, USA
Jinsong Li, Institute of Biochemistry and Cell Biology, Shanghai Institutes for biological Science, CAS, China
Guomin Li, University of Texas Southwestern Medical Center, USA
Shengcai Lin, School of Life Sciences, Xiamen University, China
Shuo Lin, Department of Molecular, Cell & Developmental Biology, University of California, USA
Feng Lin, Cleveland Clinic Lerner Research Institute, USA
Lin Liu, College of Life Sciences, Nankai University, Tianjin, China
Mofang Liu, Shanghai Institute of Biochemistry and Cell Biology, CAS, China
Yu Liu, West China Hospital, Sichuan University, China
Nathan Luedtke, University of Zurich, Switzerland
Pralay Maiti, Indian Institute of Technology (Banaras Hindu University), India
Guido Marcucci, City of Hope Comprehensive Cancer Center, USA
Ruggero De Maria, Istituto Superiore di Sanita, Italy
Ingo Mellinghoff, Memorial Sloan-Kettering Cancer Center, New York, USA
Karl Munger, Tufts Medical Center, USA
Liang Ouyang, West China Hospital, Sichuan University, China
Lianghu Qu, Sun Yat-sen University, China
Zihe Rao, Tsinghua University, China
Steve Rokita, Johns Hopkins University, USA
Kanaga Sabapathy, Duke University, USA
Shree Ram Singh, The Basic Research Laboratory, National Cancer Institute at Frederick, National Institutes of Health, USA
Erwei Song, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, China
Bing Su, Shanghai Institute of Immunology, Shanghai JiaoTong University School of Medicine, China
Ming Tan, USA Mitchell Cancer Institute, USA
Yongguang Tao, Central South University, China
David Tuveson, Cold Spring Habor Laboratory, USA
Daowen Wang, Huazhong University of Science and Technology, China
Xiaofan Wang, Duke University, USA
Yongsheng Wang, West China Hospital, Sichuan University
Min Wu, Department of Basic Sciences, University of North Dakota, USA
Hao Wu, Harverd Medical School and Boston Children's Hospital, USA
Di Xia, National Institutes of Health, USA
Xiao Xiao, Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, USA
Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA
Tian Xu, Howard Hughes Medical Institute & Yale University School of Medicine, USA
Xianjie Yang, UCLA School of Medicine, USA
Pengyuan Yang, Institutes of Biomedical Sciences, Fudan University, China
Dihua Yu, The University of Texas MD Anderson Cancer Center, USA
Junying Yuan, Department of Cell Biology，Harvard Medical School, USA
Qimin Zhan, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China
Zhiguo Zhang, Columbia University, USA
Shimin Zhao, State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai , China
Pan Zheng, Children's National Medical Center, USA
Weimin Zhong, Yale University, USA
Qi Zhou, State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, China
Weiguo Zhu, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Biochemistry and Molecular Biology, Peking University Health Science Center, China